XML 10 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 26,701 $ 24,322
General and administrative 6,590 8,004
Total operating expenses 33,291 32,326
Loss from operations (33,291) (32,326)
Other income:    
Interest income 805 1,522
Total other income 805 1,522
Net loss $ (32,486) $ (30,804)
Net loss per share attributable to common stockholders, basic $ (0.26) $ (0.45)
Net loss per share attributable to common stockholders, diluted $ (0.26) $ (0.45)
Weighted-average common shares outstanding, basic 124,824,147 68,030,966
Weighted-average common shares outstanding, diluted 124,824,147 68,030,966
Other comprehensive income (loss):    
Unrealized gain (loss) on available for sale marketable securities $ 1 $ (10)
Total other comprehensive income (loss): 1 (10)
Comprehensive loss $ (32,485) $ (30,814)